DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "World DNA Sequencing Market - Opportunities and Forecasts, 2014 - 2022" report to their offering.
DNA sequencing is the process of arranging nucleotide molecule of DNA. DNA sequencing market is a segment of life science tools market, which was valued more than $40 billion in 2011. The global market for DNA sequencing is driven by emergence of Human Genome Project that provides cost effective and improved DNA sequencing. For Example, there were more than $ 1 million required to store human genome information in 2007. DNA sequencing is competing with conventional genetic analysis tools. New technologies in conventional genetic analysis compete with DNA sequencing by providing cost effective genetic analysis solutions.
The global DNA sequencing market is facing challenges in commercialization of sequencing tools; however, government and research facilities are funding the sequencing technologies so that companies can get opportunities for expanding their businesses in microarray and in vitro diagnostics. This report provides intelligence about current market trends available in DNA sequencing market. The report provides an in depth analysis of key regulations and reimbursement policies for conducting DNA sequencing.
Key companies included in the report are, Agilent Technologies Inc., AltheaDx, Axeq Technologies, Base4innovation Ltd., Bio.Logis Gmbh, Biomatters Ltd., Dna Vision, Electronic Biosciences, Foundation Medicine, GATC Biotech Ag.
Scope of the Report:
BY END USER MARKET
- Bioinformatics market
- Sample preparation market
- Instruments market
- Services market
- Research, drug discovery
- North America
For more information about this report visit http://www.researchandmarkets.com/research/3k9mpj/world_dna